image goes here
Is Your Site Ready to Conduct Gene Therapy Research?
Gene therapy-based products are entering human trials at an exponential growth rate. Is your research site ready to participate?
In this webinar, we examine the basics of conducting human gene therapy research as well as the requirements for institutional biosafety committee (IBC) review as outlined in National Institutes of Health (NIH) Office of Science Policy guidelines. Our experts will also prepare you and your site for when the next human gene therapy trial comes along.
Learning Objectives:
- Define basic regulations and guidelines governing IBCs and gene therapy research
- Outline key ways to prepare your site to participate in this growing research field
- Explain the IBC’s role and how the oversight is different from IRB
Presented By
James Riddle
MCSE, CIP, CPIA, CRQM
Vice President, Research Services & Strategic Consulting
Advarra
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
DATE: June 23, 2021
Time: 3 pm ET | 12 pm PT
Duration: 1 hour